 Amanda Piquet
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalitis | 7 | 2023 | 127 | 4.210 |
Why?
| | Meningitis | 4 | 2023 | 74 | 2.090 |
Why?
| | Meningoencephalitis | 2 | 2021 | 24 | 1.440 |
Why?
| | Hashimoto Disease | 2 | 2020 | 9 | 1.370 |
Why?
| | Autoantibodies | 8 | 2023 | 1350 | 1.200 |
Why?
| | Stiff-Person Syndrome | 2 | 2024 | 7 | 1.080 |
Why?
| | Autoimmune Diseases of the Nervous System | 2 | 2023 | 21 | 1.040 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2023 | 79 | 0.910 |
Why?
| | Nervous System Diseases | 3 | 2023 | 252 | 0.840 |
Why?
| | Enterovirus A, Human | 1 | 2021 | 12 | 0.760 |
Why?
| | Rituximab | 1 | 2021 | 150 | 0.710 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2021 | 63 | 0.710 |
Why?
| | Myelitis | 1 | 2021 | 88 | 0.690 |
Why?
| | Interferon-gamma | 1 | 2023 | 722 | 0.690 |
Why?
| | Neuromuscular Diseases | 1 | 2021 | 89 | 0.690 |
Why?
| | Immunologic Factors | 1 | 2021 | 220 | 0.650 |
Why?
| | Oxidoreductases | 1 | 2019 | 92 | 0.630 |
Why?
| | Enterovirus Infections | 1 | 2021 | 160 | 0.630 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 524 | 0.620 |
Why?
| | Autoimmune Diseases | 2 | 2018 | 391 | 0.590 |
Why?
| | Immunoglobulin G | 2 | 2023 | 774 | 0.540 |
Why?
| | Autoimmunity | 2 | 2018 | 814 | 0.520 |
Why?
| | T-Lymphocytes | 1 | 2023 | 1745 | 0.510 |
Why?
| | Nuclear Proteins | 1 | 2019 | 592 | 0.480 |
Why?
| | Nerve Tissue Proteins | 3 | 2023 | 529 | 0.440 |
Why?
| | Paraneoplastic Syndromes, Nervous System | 2 | 2023 | 9 | 0.420 |
Why?
| | Dopaminergic Neurons | 2 | 2015 | 43 | 0.420 |
Why?
| | Parkinson Disease | 2 | 2019 | 345 | 0.410 |
Why?
| | Brain Tissue Transplantation | 1 | 2012 | 19 | 0.410 |
Why?
| | Breast Neoplasms | 1 | 2022 | 1868 | 0.370 |
Why?
| | Flavivirus Infections | 2 | 2019 | 9 | 0.340 |
Why?
| | Humans | 25 | 2024 | 114757 | 0.300 |
Why?
| | Receptors, Glycine | 1 | 2024 | 4 | 0.230 |
Why?
| | Paraneoplastic Cerebellar Degeneration | 1 | 2023 | 1 | 0.230 |
Why?
| | Medical Tourism | 1 | 2023 | 9 | 0.220 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 176 | 0.220 |
Why?
| | Flavivirus | 2 | 2019 | 16 | 0.210 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 249 | 0.210 |
Why?
| | Encephalomyelitis | 1 | 2022 | 9 | 0.210 |
Why?
| | Astrocytes | 1 | 2023 | 162 | 0.200 |
Why?
| | Exanthema | 1 | 2022 | 74 | 0.200 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 98 | 0.190 |
Why?
| | Eosinophils | 1 | 2023 | 278 | 0.190 |
Why?
| | Receptors, AMPA | 1 | 2022 | 120 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 221 | 0.190 |
Why?
| | Emergencies | 1 | 2022 | 146 | 0.180 |
Why?
| | Antibodies, Viral | 1 | 2023 | 521 | 0.170 |
Why?
| | Piperazines | 1 | 2022 | 311 | 0.170 |
Why?
| | Sexual and Gender Minorities | 1 | 2022 | 138 | 0.170 |
Why?
| | Middle Aged | 6 | 2023 | 26757 | 0.170 |
Why?
| | Encephalomyelitis, Eastern Equine | 1 | 2019 | 6 | 0.170 |
Why?
| | Bunyaviridae Infections | 1 | 2019 | 6 | 0.170 |
Why?
| | Encephalitis, California | 1 | 2019 | 11 | 0.170 |
Why?
| | Encephalitis, Tick-Borne | 1 | 2019 | 8 | 0.170 |
Why?
| | Arbovirus Infections | 1 | 2019 | 17 | 0.170 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 935 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 284 | 0.160 |
Why?
| | Pyridines | 1 | 2022 | 425 | 0.160 |
Why?
| | Glutamate Decarboxylase | 1 | 2019 | 160 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 333 | 0.160 |
Why?
| | Syndrome | 1 | 2019 | 334 | 0.150 |
Why?
| | B-Lymphocytes | 1 | 2023 | 769 | 0.150 |
Why?
| | Spinal Cord Diseases | 1 | 2018 | 38 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2020 | 152 | 0.150 |
Why?
| | Multiple Sclerosis | 1 | 2023 | 380 | 0.150 |
Why?
| | Lyme Neuroborreliosis | 1 | 2017 | 2 | 0.140 |
Why?
| | Male | 10 | 2023 | 55579 | 0.140 |
Why?
| | Paralysis | 1 | 2017 | 66 | 0.140 |
Why?
| | Central Nervous System Infections | 1 | 2016 | 36 | 0.130 |
Why?
| | Retinal Pigment Epithelium | 1 | 2015 | 58 | 0.120 |
Why?
| | Female | 7 | 2023 | 59507 | 0.120 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 107 | 0.120 |
Why?
| | Aged | 3 | 2021 | 19094 | 0.110 |
Why?
| | Adult | 4 | 2023 | 30548 | 0.100 |
Why?
| | Proteins | 1 | 2018 | 912 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2018 | 1022 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1340 | 0.100 |
Why?
| | Neoplasms | 1 | 2023 | 2105 | 0.090 |
Why?
| | Prospective Studies | 1 | 2019 | 6217 | 0.080 |
Why?
| | Adolescent | 3 | 2023 | 17808 | 0.070 |
Why?
| | Substance-Related Disorders | 1 | 2015 | 947 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 3039 | 0.060 |
Why?
| | Young Adult | 1 | 2019 | 10463 | 0.060 |
Why?
| | District of Columbia | 1 | 2022 | 24 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2022 | 12 | 0.050 |
Why?
| | Biomarkers | 2 | 2023 | 3416 | 0.050 |
Why?
| | Limbic Encephalitis | 1 | 2021 | 3 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2023 | 372 | 0.050 |
Why?
| | Animals | 4 | 2019 | 31762 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 121 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 249 | 0.050 |
Why?
| | Homosexuality, Male | 1 | 2022 | 170 | 0.050 |
Why?
| | Bunyamwera virus | 1 | 2019 | 3 | 0.040 |
Why?
| | Encephalitis Virus, California | 1 | 2019 | 6 | 0.040 |
Why?
| | Acute Disease | 1 | 2022 | 912 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 546 | 0.040 |
Why?
| | North America | 1 | 2019 | 257 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2023 | 664 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2018 | 48 | 0.040 |
Why?
| | Borrelia burgdorferi Group | 1 | 2017 | 8 | 0.040 |
Why?
| | Antibodies, Bacterial | 1 | 2017 | 119 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12515 | 0.030 |
Why?
| | Retinal Pigments | 1 | 2015 | 5 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2018 | 386 | 0.030 |
Why?
| | Drug-Seeking Behavior | 1 | 2015 | 22 | 0.030 |
Why?
| | Self Administration | 1 | 2015 | 123 | 0.030 |
Why?
| | Ventral Tegmental Area | 1 | 2015 | 45 | 0.030 |
Why?
| | Conditioning, Operant | 1 | 2015 | 97 | 0.030 |
Why?
| | Extinction, Psychological | 1 | 2015 | 78 | 0.030 |
Why?
| | Spinal Cord | 1 | 2017 | 347 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 475 | 0.030 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 124 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 3334 | 0.030 |
Why?
| | Cocaine | 1 | 2015 | 153 | 0.030 |
Why?
| | Reward | 1 | 2015 | 211 | 0.030 |
Why?
| | Dopamine | 1 | 2015 | 236 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4086 | 0.030 |
Why?
| | Prefrontal Cortex | 1 | 2015 | 262 | 0.030 |
Why?
| | Child | 2 | 2023 | 18352 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 1812 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6350 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2015 | 2209 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 955 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 9089 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1477 | 0.020 |
Why?
| | Rats | 1 | 2015 | 4943 | 0.020 |
Why?
| | United States | 1 | 2022 | 12176 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9079 | 0.020 |
Why?
|
|
Piquet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|